Fall 2023

This Fall 2023 edition of the LipidSpin on Diabesity is sponsored by NELA and SELA Chapters. The 2023 NELA Chapter and Board would like to thank all the authors, contributors, and editors who shared their expertise to make this an informative and valuable issue of LipidSpin. Despite the... more

0
No votes yet

The 2023 Scientific Sessions in June were well attended and provided superb learning opportunities for all. As always, this was a time to connect and network with old and new colleagues and friends. SELA president, Jan McAlister, DNP, CLS, FNLA and Mary Katherine Cheeley, PharmD, BCPS, CLS,... more

0
No votes yet

The Foundation of the NLA did something a little different this year – instead of hosting a black-tie gala event, we opted for a more casual affair, filled with light bites and vintage arcade games! The evening was full of good conversation, and friendly competition. We appreciate those who made it... more

0
No votes yet

The National Lipid Association (NLA) is pleased to announce that 90 abstracts were accepted for presentation in the poster format for the NLA 2023 Scientific Sessions. Each abstract was reviewed by the NLA Scientific Sessions Abstracts Committee prior to acceptance. Posters were judged on quality... more

0
No votes yet

Oby Ibe, MD, MPH Cardiology Postdoctoral Fellow Temple University Hospital  Oby B. Ibe, MD, MPH is a third year General Cardiology fellow at Temple University Hospital. She completed her Internal Medicine Residency at the Hospital of the University of Pennsylvania and earned a Master’s... more

0
No votes yet

Introduction Cardiometabolic syndrome is an aggregation of cardiovascular, metabolic, and renal abnormalities that includes central/visceral obesity, hyperinsulinemia, hypertension, and dyslipidemia.1 Approximately 47 million individuals in the United States are currently living with... more

0
No votes yet

Introduction/Magnitude of The Problem Diabetes mellitus (DM) is a systemic disease of abnormal carbohydrate metabolism leading to chronic hyperglycemia. It is a major contributor to chronic disease and death, both in the United States (U.S.) and globally. Notably, more than 37 million U.S.... more

0
No votes yet

Clinical Case The patient is a 67-year-old white gentleman with type 2 diabetes mellitus (T2DM), hypertension (HTN), 20-pack-year smoking history, and dyslipidemia. He presented to the Lipidology Clinic for a follow-up of his diabetes and atherogenic dyslipidemia. He has never experienced any... more

0
No votes yet

This issue is sponsored by the Northeast and Southeast Lipid Associations

0
No votes yet

Hello NLA members, I hope everyone had a wonderful summer. As our long, warm days move into cool fall nights, the NLA continues to charge ahead, expanding educational opportunities for providers to combat the rise of cardiovascular disease.  The fall CLU in Scottsdale, Arizona, will go... more

0
No votes yet